Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (83)	7/4/2003 12:57:12 AM
From: mopgcw	Read Replies (1) \| Respond to of 411

CV Therapeutics Inc (NasdaqNM: CVTX) filed an 8-K on 7/3, in which the Company reported that on July 3, 2003, it entered into an equity line of credit arrangement with Acqua Wellington North American Equities Fund, Ltd. Specifically, the Company entered into a common stock purchase agreement with Acqua Wellington, which provides that Acqua Wellington is committed to purchase up to $100,000,000 of shares of the Company's common stock, or the number of shares which is one less than twenty percent of the issued and outstanding shares of the Company's common stock as of July 3, 2003, whichever occurs first, over the 28-month term of the purchase agreement.